Table 1.

Cytoplasmic tyrosine kinase (CTK) and receptor tyrosine kinase (RTK) genes resequenced in primary AML patient samples

Set	Gene name	Locus ID	Total no. of exons	No. of exons covered (discovery tumor)	No. of amplicons sequenced (discovery tumor)	No. of amplicons sequenced (discovery germline)	No. of amplicons sequenced (CALGB)
CTK	ABL1	25	10	6	6	2	1
CTK	BTK	695	19	6	6	0	0
RTK	CSF1R	1436	22	11	15	5	0
CTK	CSK	1445	12	8	19	0	0
RTK	DDR1	780	19	6	8	5	1
RTK	EPHB1	2047	16	7	8	2	0
CTK	FES	2242	19	7	6	1	1
RTK	FGFR1	2260	18	8	7	2	0
CTK	FGR	2268	11	6	4	0	0
RTK	FLT3	2322	24	2	5	2	2
CTK	FYN	2534	11	7	7	0	1
CTK	HCK	3055	13	6	6	2	2
RTK	IGF1R	3480	21	6	7	0	0
RTK	INSR	3643	22	6	10	3	0
CTK	JAK1	3716	24	24	33	33	33
CTK	JAK2	3717	25	14	20	10	1
CTK	JAK3	3718	23	15	16	2	2
RTK	KIT	3815	21	2	2	2	1
RTK	LTK	4058	20	10	10	7	3
CTK	LYN	4067	13	6	22	1	1
RTK	NTRK1	4914	17	5	7	4	3
CTK	PTK2B	2185	36	8	8	0	0
RTK	RYK	6259	14	8	8	0	0
CTK	SYK	6850	14	6	6	0	0
CTK	TYK2	7297	25	23	33	7	9
CTK	YES1	7525	11	6	7	0	0
		Total	480	219	286	90	61